These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20683061)

  • 1. CCND1 and CDKN1B polymorphisms and risk of breast cancer.
    Canbay E; Eraltan IY; Cercel A; Isbir T; Gazioglu E; Aydogan F; Cacina C; Cengiz A; Ferahman M; Zengin E; Unal H
    Anticancer Res; 2010 Jul; 30(7):3093-8. PubMed ID: 20683061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of cyclin D1 genotype with breast cancer risk and survival.
    Shu XO; Moore DB; Cai Q; Cheng J; Wen W; Pierce L; Cai H; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):91-7. PubMed ID: 15668481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer and cyclin D1 gene polymorphism in Turkish women.
    Yaylim-Eraltan I; Ergen A; Görmüs U; Arikan S; Küçücük S; Sahin O; Yigit N; Yildiz Y; Isbir T
    In Vivo; 2009; 23(5):767-72. PubMed ID: 19779113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of HER2 Ile655Val and cyclin D1 (CCND1) G870A are not associated with breast cancer risk but polymorphic allele of HER2 is associated with nodal metastases.
    Naidu R; Yip CH; Taib NA
    Neoplasma; 2008; 55(2):87-95. PubMed ID: 18237245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population.
    Yaylim-Eraltan I; Arikan S; Yildiz Y; Cacina C; Ergen HA; Tuna G; Görmüs U; Zeybek U; Isbir T
    Anticancer Res; 2010 Jul; 30(7):2875-80. PubMed ID: 20683026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
    Gautschi O; Hugli B; Ziegler A; Bigosch C; Bowers NL; Ratschiller D; Jermann M; Stahel RA; Heighway J; Betticher DC
    Lung Cancer; 2006 Mar; 51(3):303-11. PubMed ID: 16406195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of BCL2 (ala43thr), CCND1 (G870A) and FAS (A-670G) polymorphisms in modulating the risk of developing esophageal cancer.
    Jain M; Kumar S; Lal P; Tiwari A; Ghoshal UC; Mittal B
    Cancer Detect Prev; 2007; 31(3):225-32. PubMed ID: 17561354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer.
    Naidu R; Har YC; Taib NA
    J Exp Clin Cancer Res; 2007 Mar; 26(1):133-40. PubMed ID: 17550142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer.
    Bedewy AM; Mostafa MH; Saad AA; El-Maghraby SM; Bedewy MM; Hilal AM; Kandil LS
    J BUON; 2013; 18(1):227-38. PubMed ID: 23613410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDR1 C3435T polymorphism in patients with breast cancer.
    Turgut S; Yaren A; Kursunluoglu R; Turgut G
    Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GG genotype of cyclin D1 G870A polymorphism is associated with non-cardiac gastric cancer in a high-risk region of China.
    Jia A; Gong J; Li Y; Hao Z; Chang X; Dai F; Yu B
    Scand J Gastroenterol; 2008; 43(11):1353-9. PubMed ID: 18609126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDKN1B V109G polymorphism frequency and prostate cancer risk in Taiwan.
    Huang SP; Yu CC; Liu CC; Wu TT; Huang CH; Wu MT
    Urol Int; 2008; 81(1):36-40. PubMed ID: 18645269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1.
    Yu CP; Yu JC; Sun CA; Tzao C; Ho JY; Yen AM
    Breast Cancer Res Treat; 2008 Jan; 107(1):95-102. PubMed ID: 18043898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between polymorphisms of the BRCA2 gene and clinical parameters in breast cancer.
    Krupa R; Sliwinski T; Morawiec Z; Pawlowska E; Zadrozny M; Blasiak J
    Exp Oncol; 2009 Dec; 31(4):250-1. PubMed ID: 20010525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the cyclin D1 A870G polymorphism on susceptibility to sporadic colorectal cancer in Taiwan.
    Huang WS; Tang R; Lin PY; Changchien CR; Chen JS; Chiang JM; Yeh CY; Wang JY; Hsieh LL
    Dis Colon Rectum; 2006 May; 49(5):602-8. PubMed ID: 16552496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancers.
    Grieu F; Malaney S; Ward R; Joseph D; Iacopetta B
    Anticancer Res; 2003; 23(5b):4257-9. PubMed ID: 14666635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma.
    Sathyan KM; Nalinakumari KR; Abraham T; Kannan S
    Oral Oncol; 2008 Jul; 44(7):689-97. PubMed ID: 18061526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of CCND1 genotype and smoking habit in Taiwan lung cancer patients.
    Hsia TC; Liu CJ; Lin CH; Chang WS; Chu CC; Hang LW; Lee HZ; Lo WC; Bau DT
    Anticancer Res; 2011 Oct; 31(10):3601-5. PubMed ID: 21965784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of cyclin D1 (CCND1) G870A-polymorphism on breast cancer risk is modified by oxidative stress among Chinese women in Singapore.
    Ceschi M; Sun CL; Van Den Berg D; Koh WP; Yu MC; Probst-Hensch N
    Carcinogenesis; 2005 Aug; 26(8):1457-64. PubMed ID: 15845652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin D1 polymorphism and the risk of endometrial cancer.
    Kang S; Kim JW; Park NH; Song YS; Kang SB; Lee HP
    Gynecol Oncol; 2005 May; 97(2):431-5. PubMed ID: 15863141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.